|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Interest and other income (expense), net | ||||
| Unrealized loss on marketable securities | ||||
| Other income, net | ||||
| Net loss | ||||
| Net loss per share, basic (usd per share) | ||||
| Net loss per share, diluted (usd per share) | ||||
| Weighted-average, common shares outstanding, basic (in shares) | ||||
| Weighted-average, common shares outstanding, diluted (in shares) | ||||
| Other comprehensive income | ||||
| Unrealized gain on investments | ||||
| Comprehensive loss | ||||
Loading...
